Tag: The Lancet

  • Cervical cancer risk doubles in women with mental disorder: Study

    Cervical cancer risk doubles in women with mental disorder: Study

    Solna [Sweden], March 24 (ANI): Women suffering from mental illness, neuropsychiatric disability or substance abuse are less likely to undergo gynecological screening tests for cervical cancer and are more than twice as likely to develop the disease. Researchers from Karolinska Institutet revealed their findings in The Lancet Public Health, emphasizing the need to engage these…

  • Almost half of all young Finns believe that humanity is doomed, according to a global study on climate change

    Almost half of all young Finns believe that humanity is doomed, according to a global study on climate change

    Helsingin sanomat newspaper reports that 43 per cent of young Finns believe that “humanity is doomed” compared to the world average of 56 per cent. In addition, 54 percent of Finns believe the government is lying about the effectiveness of its climate policy, while the global figure is 64 percent. Only 36 percent of all…

  • Atrial fibrillation screening can reduce the risk of stroke

    Atrial fibrillation screening can reduce the risk of stroke

    Stockholm [Sweden], 4 September (ANI): A study at Karolinska Institutet in Sweden has found that screening for atrial fibrillation in 75- and 76-year-olds can reduce the risk of stroke, severe bleeding and death. The study was published in The Lancet. Atrial fibrillation, a form of arrhythmia or irregular heartbeat, is associated with a fivefold increased…

  • Heart disease increasing threat to women in the world

    Heart disease increasing threat to women in the world

    Women’s cardiovascular disease must be taken more seriously by healthcare, the research world and decision-makers, leading researchers write in a new report published in the medical journal The Lancet. 275 million women live with cardiovascular disease in the world, but many receive neither diagnosis nor treatment, according to the report. Sedentary and overweight during the…

  • Double danger in Corona: Over 65s are more likely to catch it twice

    Double danger in Corona: Over 65s are more likely to catch it twice

    According to a study from the Statens Serum Institut, which involved more than 11,000 people in Denmark who have contracted coronavirus, people over the age of 65 are more susceptible to catching the virus twice. The study showed that 72 of the population – then 0.65 percent in total – tested positive for corona twice:…

  • Only every second over 65 develops immunity after infection

    Every fifth person infected with covid-19 does not become immune to new infections. For people over the age of 65, less than half build up immunity to becoming infected again. It shows a study conducted by the Statens Serum Institut (SSI), the institute writes in a press release. Senior researcher Steen Ethelberg emphasizes in the…

  • EU foreign policy chief praises Russian vaccine success

    EU foreign policy chief praises Russian vaccine success

    During a visit to Moscow today, EU Foreign Minister Josep Borrell congratulated Russia on the country’s success with its covid-19 vaccine. An article published in The Lancet shows that the vaccine, Sputnik V, has a 92% efficacy against the disease. Russia has previously been criticized for rushing its vaccine, but now there are hopes that…

  • Two out of three severe covids have symptoms for several months

    Two out of three severe covids have symptoms for several months

    The vast majority of people hospitalized for covid-19 still have symptoms six months later, according to a study from China based on analyzes of 1,733 patients hospitalized in Wuhan. Among these, 76 percent had at least one residual symptom, of which fatigue and muscle weakness were the most common, while the lungs and kidneys were…

  • Signs that Russian vaccine develops antibodies

    Signs that Russian vaccine develops antibodies

    The famous Russian vaccine against the new coronavirus has now been evaluated for the first time. These are two smaller studies with a total of 76 participants. Forty-two days after vaccination, no serious side effects were seen and after three weeks, all participants had developed antibodies to the virus. The research is published in the…